Carlsmed announced successful completion of the first posterior lumbar spine surgery using the company’s aprevo Lumbar Bi-lateral Posterior System. The system is slated for commercial launch during 2026.
Carlsmed’s Bi-lateral Posterior Fusion System integrates seamlessly with the company’s broader aprevo platform technology, which combines proprietary AI-enabled software and clinical intelligence to deliver personalized surgical strategies and preoperative planning across a range of spinal pathologies.
Mike Cordonnier, Chairman and CEO of Carlsmed, said, “The addition of the aprevo Bi-lateral Posterior Lumbar Interbody Fusion procedure to our personalized surgery procedure portfolio further demonstrates the power and versatility of our personalized, AI-enabled approach to spine surgery.”
Carlsmed announced successful completion of the first posterior lumbar spine surgery using the company’s aprevo Lumbar Bi-lateral Posterior System. The system is slated for commercial launch during 2026.
Carlsmed’s Bi-lateral Posterior Fusion System integrates seamlessly with the company’s broader aprevo platform technology, which combines...
Carlsmed announced successful completion of the first posterior lumbar spine surgery using the company’s aprevo Lumbar Bi-lateral Posterior System. The system is slated for commercial launch during 2026.
Carlsmed’s Bi-lateral Posterior Fusion System integrates seamlessly with the company’s broader aprevo platform technology, which combines proprietary AI-enabled software and clinical intelligence to deliver personalized surgical strategies and preoperative planning across a range of spinal pathologies.
Mike Cordonnier, Chairman and CEO of Carlsmed, said, “The addition of the aprevo Bi-lateral Posterior Lumbar Interbody Fusion procedure to our personalized surgery procedure portfolio further demonstrates the power and versatility of our personalized, AI-enabled approach to spine surgery.”
Copy to clipboard 
